Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.
about
Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitroNew insights into the use of currently available non-steroidal anti-inflammatory drugsPiroxicam-β-cyclodextrin: a GI safer piroxicamGastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategiesUse of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarctionSafety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring studyA Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine ModelSafe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risksNon-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks.Diclofenac inhibits tumor growth in a murine model of pancreatic cancer by modulation of VEGF levels and arginase activityNaproxen and Diclofenac Attenuate Atorvastatin-induced Preconditioning of the Myocardium.Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiativeBiological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.Cyclo-oxygenase-2 inhibition and endothelium-dependent vasodilation in younger vs. older healthy adults.COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood.Naproxen attenuates sensitization of depressive-like behavior and fever during maternal separation.Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.Intravenous non-opioid analgesia for peri- and postoperative pain management: a scientific review of intravenous acetaminophen and ibuprofen.Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbitUp-Regulation of the Biosynthesis and Release of Substance P through Wnt/β-Catenin Signaling Pathway in Rat Dorsal Root Ganglion CellsEffects of tipranavir, darunavir, and ritonavir on platelet function, coagulation, and fibrinolysis in healthy volunteers.An integrated safety analysis of intravenous ibuprofen (Caldolor(®)) in adults.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentCyclooxygenase products and atherosclerosisVasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Finding multiple target optimal intervention in disease-related molecular network.Cyclooxygenase (COX) Inhibitors and the Newborn Kidney.The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers.A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin.Comparison of preemptive analgesic effects of a single dose of nonopioid analgesics for pain management after ambulatory surgery: A prospective, randomized, single-blind studyin Turkish patients.Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs.Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen.On the functionalization of benzo[e][2,1]thiazine.Platelet function analyser (PFA)-100 closure time in the evaluation of non-steroidal anti-inflammatory drug-induced platelet dysfunction in children with bleeding symptoms.COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis?Effects of ibuprofen on cognition and NMDA receptor subunit expression across aging.Pharmacokinetics of Diclofenac and Hydroxypropyl-β-Cyclodextrin (HPβCD) Following Administration of Injectable HPβCD-Diclofenac in Subjects With Mild to Moderate Renal Insufficiency or Mild Hepatic Impairment.Effects of Exposure to Acetaminophen and Ibuprofen on Fetal Germ Cell Development in Both Sexes in Rodent and Human Using Multiple Experimental Systems.Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits.
P2860
Q24798976-C8B5F4B7-E2B3-4AA3-86E8-181737511FCEQ26852330-77AF9DA2-CA3E-44D8-B0AB-9C46024FB6D6Q27023475-E718521C-24F4-4765-844F-3669D8855FD1Q27026351-E9F4F010-9788-4800-8258-613495A22571Q28193777-DEDB19DF-F02A-4448-B487-2373362A3D6CQ28194919-8E678344-AE0C-4659-AD7A-323A38690DA8Q28551334-10978A29-F649-4ADD-A09E-05E91CCD0DE1Q30629677-C4AF95A8-DD8F-4E88-B6F7-8B44512D9D74Q33678007-D1943DEB-82F5-4A31-A945-DEE78686A305Q33697712-96687FB6-5613-475B-8772-0124A30D54ADQ33732277-2348167B-1386-4CD2-9BFF-BD517098F083Q34117657-0A29FDEC-6A99-4C06-A25B-364A442954EBQ34245387-8B0DA2BE-26CB-4C3D-BC2B-CEF03B641284Q34554429-72743445-B7AC-4145-9E8A-36B77F9CB0F9Q34580278-C9D6AE49-DC66-4750-8964-C4CE9E4510C5Q34765056-6056E700-0A75-4A7E-9BED-7E216CA4E045Q35044973-204A092C-000D-4A70-8612-F36729877020Q35054937-F5CDB24F-8C5A-473B-A8C0-81FE1EBD3265Q35287418-4FC74A8E-3188-4E7F-B1EF-15C14D98F247Q35656935-7727CC9D-BCC2-4DEE-BE91-2F9B496ED828Q35932065-E5316255-10A7-405F-841C-D09FE261C0FEQ36244274-EB75DB44-D3F1-444F-8D01-790E3302BFA0Q36483712-45C1D7C4-C29B-426D-BC2C-2E3779ECF554Q37071164-9A532C6E-1B23-4B9C-A1BF-4D1633FB5E40Q37102697-720C5BEF-D64E-4860-806E-B83EB664B62DQ37170511-5D7A4336-ADFB-41F9-8B1C-B3A7FACB4083Q37277333-7FD1E16C-E455-49F8-99D3-9790FAEFBF10Q37332627-C8866968-7CFA-4CBC-8DF9-801DD27DECA4Q37518156-C8882089-0F7A-434B-A5FB-8E687004E5FEQ37663575-FFFBBBF5-8D13-4F5A-AEF6-17B7910F69A3Q38262502-F6E5A3D8-FF7D-4F13-A4DA-FB8497F42844Q41020386-0C7EF8B4-3DB2-4A7C-800E-A8E15737D503Q42137850-7FB63D51-0749-4728-87A8-9C34D0155CEDQ42343637-3AB9C907-D0B1-4E77-8954-B2A0B65EBDB4Q42743950-C4A1BC69-6433-4CB1-89F0-18E095DDAA23Q48370811-8C2BB1CF-221D-4A25-A6A0-9BAA5EE77A69Q49350307-AFD09E71-4219-4C46-8713-54E613C0F0BAQ52582779-5C0EFE64-8A85-4F25-91AE-809833E10873Q55071130-92510AB1-B82F-4391-A1E5-E83DAA6B54A1
P2860
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@ast
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@en
type
label
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@ast
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@en
prefLabel
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@ast
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@en
P2093
P1476
Comparative inhibitory activit ...... s COX-1 in healthy volunteers.
@en
P2093
A Van Hecken
I De Lepeleire
J I Schwartz
P304
P577
2000-10-01T00:00:00Z